Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Principles of method if other than guideline:
An acute dermal toxicity study was conducted with the test substance on 5 male and 5 female rats with an exposure period of 24 hours and an observation period of 14 days.
GLP compliance:
no
Remarks:
Study pre-dates GLP regulations
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
Aluminum, hydroxy[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chloro sulfo derivs., sodium salts
EC Number:
307-259-1
EC Name:
Aluminum, hydroxy[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chloro sulfo derivs., sodium salts
Cas Number:
97592-62-6
Molecular formula:
not available
IUPAC Name:
Aluminum, hydroxy[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chloro sulfo derivs., sodium salts
Test material form:
solid
Specific details on test material used for the study:
- Test substance name as used in the study report: FAT 60149/B.

Test animals

Species:
rat
Strain:
other: Tif: RAIf (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 8 to 9 weeks
- Weight at study initiation: Mean group body weight Males 212-218 g; Females: 182-204 g
- Housing: Individually in Macrolon cages (type 2)
- Diet: ad libitum rat food - NAFAG, Gossau SG
- Water: ad libitum
- Acclimation period: at least 4 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Photoperiod (hrs dark / hrs light): 14 / 10

Administration / exposure

Type of coverage:
occlusive
Vehicle:
polyethylene glycol
Details on dermal exposure:
Approximately 24 hours before treatment an area on the back of the rats of approximately 60 square cm was shaved with an electric clipper. For treatment the test material was evenly dispersed on the skin with a syringe and was covered with an occlusive dressing which was fastened around the trunk with an adhesive elastic bandage. After 24 hours the dressing was removed, the skin was cleaned with lukewarm water and the reaction of the skin was appraised.
Duration of exposure:
24 hours
Doses:
2000, 2500, 3000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
yes, concurrent vehicle
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: 1, 2, 3, 5, 24 hours after administration, then daily
- Frequency of weighing: before administration, at 7 and 14 days.
- Necropsy of survivors performed: yes
- Other examinations performed: histopathology
Statistics:
LD50 including 95 % confidence limits are calculated by the logit model.

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 3 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortallity occurred at the tested concentrations.
Clinical signs:
other: - Controls: no clinical symptoms - 2000 mg/kg bw: dyspnoea, exophthalmos, ruffled fur, curved body position. No symptoms after day 7. - 2500 mg/kg bw: same symptoms as above. - 3000 mg/kg bw: same symptoms as above.
Gross pathology:
At autopsy of treated and control rats no gross pathological changes were seen. At the site of the dermal treatment neither macroscopical nor histopathological findings which could be related to the dermal application of the substance were noted.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met